IFP Advisors’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25K | Sell |
108
-482
| -82% | -$6.01K | ﹤0.01% | 4127 |
|
|
2025
Q4 | $6.74K | Sell |
590
-3,437
| -85% | -$40.3K | ﹤0.01% | 3261 |
|
|
2025
Q3 | $51.1K | Buy |
4,027
+216
| +6% | +$3.13K | ﹤0.01% | 2065 |
|
|
2025
Q2 | $60.5K | Buy |
3,811
+3,439
| +924% | +$51.4K | ﹤0.01% | 1952 |
|
|
2025
Q1 | $5.56K | Buy |
372
+111
| +43% | +$1.97K | ﹤0.01% | 2796 |
|
|
2024
Q4 | $4.95K | Buy |
261
+240
| +1,143% | +$5.08K | ﹤0.01% | 2798 |
|
|
2024
Q3 | $568 | Sell |
21
-61
| -74% | -$1.56K | ﹤0.01% | 3140 |
|
|
2024
Q2 | $2.04K | Buy |
82
+33
| +67% | +$946 | ﹤0.01% | 2809 |
|
|
2024
Q1 | $1.63K | Sell |
49
-57
| -54% | -$1.95K | ﹤0.01% | 2751 |
|
|
2023
Q4 | $3.77K | Buy |
106
+26
| +33% | +$825 | ﹤0.01% | 2509 |
|
|
2023
Q3 | $2.73K | Hold |
80
| – | – | ﹤0.01% | 2734 |
|
|
2023
Q2 | $3.2K | Sell |
80
-49
| -38% | -$1.95K | ﹤0.01% | 2705 |
|
|
2023
Q1 | $5.6K | Sell |
129
-7
| -5% | -$257 | ﹤0.01% | 2518 |
|
|
2022
Q4 | $6K | Sell |
136
-148
| -52% | -$4.46K | ﹤0.01% | 3734 |
|
|
2022
Q3 | $13K | Buy |
284
+15
| +6% | +$513 | ﹤0.01% | 3485 |
|
|
2022
Q2 | $12K | Hold |
269
| – | – | ﹤0.01% | 3280 |
|
|
2022
Q1 | $12K | Buy |
269
+149
| +124% | +$7.88K | ﹤0.01% | 3280 |
|
|
2021
Q4 | $8K | Sell |
120
-818
| -87% | -$45K | ﹤0.01% | 2321 |
|
|
2021
Q3 | $56K | Sell |
938
-2
| -0.2% | -$123 | ﹤0.01% | 1539 |
|
|
2021
Q2 | $59K | Buy |
940
+2
| +0.2% | +$132 | ﹤0.01% | 1454 |
|
|
2021
Q1 | $59K | Sell |
938
-54
| -5% | -$3.13K | ﹤0.01% | 1394 |
|
|
2020
Q4 | $52K | Sell |
992
-30
| -3% | -$1.48K | ﹤0.01% | 1426 |
|
|
2020
Q3 | $44K | Buy |
1,022
+8
| +0.8% | +$354 | ﹤0.01% | 1340 |
|
|
2020
Q2 | $43K | Sell |
1,014
-386
| -28% | -$16.3K | ﹤0.01% | 1288 |
|
|
2020
Q1 | $55K | Buy |
1,400
+348
| +33% | +$17.7K | 0.01% | 1081 |
|
|
2019
Q4 | $61K | Sell |
1,052
-121
| -10% | -$6.75K | ﹤0.01% | 1177 |
|
|
2019
Q3 | $64K | Buy |
+1,173
| New | +$63K | ﹤0.01% | 1263 |
|
|
2019
Q1 | $45K | Sell |
900
-244
| -21% | -$10.7K | 0.01% | 1012 |
|
|
2018
Q4 | $42K | Buy |
1,144
+158
| +16% | +$5.75K | ﹤0.01% | 1706 |
|
|
2018
Q3 | $37K | Sell |
986
-210
| -18% | -$8.74K | ﹤0.01% | 2066 |
|
|
2018
Q2 | $52K | Buy |
1,196
+75
| +7% | +$3.52K | ﹤0.01% | 1889 |
|
|
2018
Q1 | $74K | Hold |
1,121
| – | – | ﹤0.01% | 1564 |
|
|
2017
Q4 | $74K | Sell |
1,121
-156
| -12% | -$9.92K | ﹤0.01% | 1576 |
|
|
2017
Q3 | $76K | Buy |
1,277
+106
| +9% | +$6.3K | ﹤0.01% | 1719 |
|
|
2017
Q2 | $76K | Buy |
1,171
+41
| +4% | +$2.59K | ﹤0.01% | 1700 |
|
|
2017
Q1 | $71K | Buy |
1,130
+20
| +2% | +$1.2K | ﹤0.01% | 1717 |
|
|
2016
Q4 | $64K | Buy |
1,110
+114
| +11% | +$6.74K | ﹤0.01% | 1741 |
|
|
2016
Q3 | $59K | Sell |
996
-6
| -0.6% | -$369 | ﹤0.01% | 1709 |
|
|
2016
Q2 | $62K | Buy |
1,002
+102
| +11% | +$6.28K | ﹤0.01% | 1643 |
|
|
2016
Q1 | $45K | Sell |
900
-113
| -11% | -$6.66K | 0.01% | 1012 |
|
|
2015
Q4 | $62K | Buy |
+1,013
| New | +$60.3K | ﹤0.01% | 1476 |
|
Other funds holding XRAY
VPM
SCA
VCM
CB
AI
IFP Advisors's XRAY Position: Q1 2026 in Review
IFP Advisors reduced its Dentsply Sirona (XRAY) stake by 82% in Q1 2026, selling an estimated $6.01K and leaving 108 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #4127.
IFP Advisors first reported a position in XRAY in Q4 2015 and has held it in 41 quarters since. The position peaked at $76K in Q3 2017. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.
- IFP Advisors held 108 shares of Dentsply Sirona worth $1.25K as of Q1 2026.
- IFP Advisors sold 482 Dentsply Sirona shares in Q1 2026, an estimated $6.01K.
- Dentsply Sirona made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4127 holding.
- IFP Advisors first reported a position in Dentsply Sirona in Q4 2015 and has held it in 41 quarters since.
- IFP Advisors's Dentsply Sirona position peaked at $76K in Q3 2017.
- 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.
Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.